Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2107259rdf:typepubmed:Citationlld:pubmed
pubmed-article:2107259lifeskim:mentionsumls-concept:C0025011lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0025007lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1704387lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1522642lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:2107259lifeskim:mentionsumls-concept:C1705535lld:lifeskim
pubmed-article:2107259pubmed:issue6lld:pubmed
pubmed-article:2107259pubmed:dateCreated1990-4-16lld:pubmed
pubmed-article:2107259pubmed:abstractTextStimulation of PBMC, in children recovering from acute measles, with autologous EBV-transformed and measles virus (MV)-infected lymphoblastoid cell lines (B-LCL) expanded primarily MV-specific CD8+ T cells. A large number of CD8+ T cell clones were obtained either by passaging of bulk cultures at limiting dilutions or by direct cloning of PBMC without previous stimulation in bulk culture. The MV-specific CD8+ T cell clones responding in a proliferative and a CTL assay were found to be class I MHC restricted. In contrast, CD4+ MV-specific T cell clones, which were generated by the same protocol, recognized MV in association with class II MHC molecules. Analysis of processing requirements for Ag presentation to CD8+ and CD4+ T cell clones, measured by the effect of chloroquine in a proliferative T cell response, revealed that both types of T cells recognized MV Ag processed via the endogenous/cytoplasmic pathway. Thus, these studies indicate that, as in most other viral infections and in contrast to previous suggestions, the class I MHC-restricted CTL response by CD8+ T cells may be an important factor in the control and elimination of MV infection. Therefore, the role proposed for CD4+ class II-restricted T cells in recovery from measles needs to be reevaluated.lld:pubmed
pubmed-article:2107259pubmed:languageenglld:pubmed
pubmed-article:2107259pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2107259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2107259pubmed:statusMEDLINElld:pubmed
pubmed-article:2107259pubmed:monthMarlld:pubmed
pubmed-article:2107259pubmed:issn0022-1767lld:pubmed
pubmed-article:2107259pubmed:authorpubmed-author:OsterhausA...lld:pubmed
pubmed-article:2107259pubmed:authorpubmed-author:KuijpersK CKClld:pubmed
pubmed-article:2107259pubmed:authorpubmed-author:PoelenM CMClld:pubmed
pubmed-article:2107259pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:2107259pubmed:authorpubmed-author:UytdehaagF...lld:pubmed
pubmed-article:2107259pubmed:issnTypePrintlld:pubmed
pubmed-article:2107259pubmed:day15lld:pubmed
pubmed-article:2107259pubmed:volume144lld:pubmed
pubmed-article:2107259pubmed:ownerNLMlld:pubmed
pubmed-article:2107259pubmed:authorsCompleteYlld:pubmed
pubmed-article:2107259pubmed:pagination2394-9lld:pubmed
pubmed-article:2107259pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:meshHeadingpubmed-meshheading:2107259-...lld:pubmed
pubmed-article:2107259pubmed:year1990lld:pubmed
pubmed-article:2107259pubmed:articleTitleThe predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.lld:pubmed
pubmed-article:2107259pubmed:affiliationDepartment of Immunobiology, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.lld:pubmed
pubmed-article:2107259pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2107259pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2107259lld:pubmed